During the past decade, CMH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
2015-07-01
2023-11-01
Recruiting
782
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CMH
According to Clinical.Site data, the most researched conditions in "CMH" are
"Hemodynamic Rebound" (1 trials) and "Placenta Previa" (1 trials). Many other conditions were trialed in "CMH" in a lesser frequency.
Clinical Trials Intervention Types at CMH
Most popular intervention types in "CMH" are "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Balloon Tamponade or B-Lynch" (1 trials) and "Tracheal Intubation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CMH
The vast majority of trials in "CMH" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CMH
Currently, there are NaN active trials in "CMH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in CMH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CMH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".